首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies
【2h】

Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies

机译:从兔单克隆抗体产生稳定的人源化单链Fv片段的通用方法。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite their favorable pharmacokinetic properties, single-chain Fv antibody fragments (scFvs) are not commonly used as therapeutics, mainly due to generally low stabilities and poor production yields. In this work, we describe the identification and optimization of a human scFv scaffold, termed FW1.4, which is suitable for humanization and stabilization of a broad variety of rabbit antibody variable domains. A motif consisting of five structurally relevant framework residues that are highly conserved in rabbit variable domains was introduced into FW1.4 to generate a generically applicable scFv scaffold, termed FW1.4gen. Grafting of complementarity determining regions (CDRs) from 15 different rabbit monoclonal antibodies onto FW1.4 and their derivatives resulted in humanized scFvs with binding affinities in the range from 4.7 × 10−9 to 1.5 × 10−11 m. Interestingly, minimalistic grafting of CDRs onto FW1.4gen, without any substitutions in the framework regions, resulted in affinities ranging from 5.7 × 10−10 to <1.8 × 10−12 m. When compared with progenitor rabbit scFvs, affinities of most humanized scFvs were similar. Moreover, in contrast to progenitor scFvs, which were difficult to produce, biophysical properties of the humanized scFvs were significantly improved, as exemplified by generally good production yields in a generic refolding process and by apparent melting temperatures between 53 and 86 °C. Thus, minimalistic grafting of rabbit CDRs on the FW1.4gen scaffold presents a simple and reproducible approach to humanize and stabilize rabbit variable domains.
机译:尽管单链Fv抗体片段具有良好的药代动力学特性,但由于其稳定性通常较低,且产量较低,因此并不常用作为治疗药物。在这项工作中,我们描述了人类scFv支架(称为FW1.4)的鉴定和优化,该支架适用于各种兔抗体可变域的人源化和稳定化。将由五个在兔可变域中高度保守的结构相关框架残基组成的基序引入FW1.4中,以生成通用的scFv支架,称为FW1.4gen。将15种不同的兔单克隆抗体的互补决定区(CDRs)嫁接到FW1.4及其衍生物上,产生人源化的scFv,结合亲和力范围为4.7×10 -9 至1.5×10 −11 m。有趣的是,将CDR简约移植到FW1.4gen上,在框架区没有任何取代,亲和力范围从5.7×10 −10 到<1.8×10 −12 米与祖兔scFv相比,大多数人源化scFv的亲和力相似。此外,与难以产生的祖细胞scFv相比,人源化scFv的生物物理特性得到了显着改善,例如在一般的复性过程中总体收率良好以及表观熔解温度介于53至86°C之间。因此,在FW1.4gen支架上进行兔CDR的最小限度移植提供了一种简单且可重现的方法,可将兔可变域人源化并使其稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号